Reported 11 months ago
The Supreme Court has rejected Purdue Pharma's OxyContin settlement proposed by the Sackler family, which aimed to send $6 billion to drug treatment programs and victims' families. However, this settlement would have shielded the Sackler family from future civil litigation, leading to the Supreme Court's ruling against it. This decision affects the financial future of Purdue Pharma and the ongoing opioid crisis, putting a halt on justice for victims and delaying the company's restructuring plans.
Source: YAHOO